enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Androgen deprivation therapy - Wikipedia

   en.wikipedia.org/wiki/Androgen_deprivation_therapy

   Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...

3. Antiandrogen - Wikipedia

   en.wikipedia.org/wiki/Antiandrogen

   Estradiol and testosterone levels following a single intramuscular injection of 320 mg polyestradiol phosphate, a polymeric estradiol ester and prodrug, in men with prostate cancer. [158] Testosterone and luteinizing hormone levels with 100 mg/day oral cyproterone acetate in men.

4. Degarelix - Wikipedia

   en.wikipedia.org/wiki/Degarelix

   Degarelix, sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer. [3] [5]Testosterone is a male hormone that promotes growth of many prostate tumours and therefore reducing circulating testosterone to very low levels is often the treatment goal in the management of advanced prostate cancer.

5. Can Finasteride Lower Testosterone? (& Other Potential Side ...

   www.aol.com/finasteride-lower-testosterone-other...

   So, does finasteride lower testosterone? No. In fact, it can increase it. ... Conversely, finasteride has been found to reduce the incidence of low-grade prostate cancer. More research is needed ...

6. What Is Low Testosterone & What Causes It? - AOL

   www.aol.com/lifestyle/low-testosterone-causes...

   Low testosterone or testosterone deficiency, ... Additionally, TRT may be unsafe if you have a history of prostate cancer or other forms of cancer affected by androgen levels. If you’ve ...

7. Medical uses of bicalutamide - Wikipedia

   en.wikipedia.org/wiki/Medical_uses_of_bicalutamide

   Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...